Pharmasset News

News on Pharmasset (Ticker: VRUS) continually updated from thousands of sources around the net.

Saturday May 19 | PR-inside.com

New Market Report: Pharmasset, Inc (VRUS) - Financial and Strategic SWOT Analysis Review

Pharmasset, Inc. is a health care pharmaceutical company. The company is engaged in discovering, producing and commercializing medicines to treat viral infections.

Comment?

Sun May 06, 2012

Seeking Alpha

Gilead's Hematology Pipeline: Transformative And Under-Appreciated

Gilead is garnering a huge amount of attention from investors owing to the hepatitis C virus pipeline it got from the Pharmasset acquisition.

Comment?

Mon Apr 30, 2012

Seeking Alpha

Gilead Sciences Looks For Hepatitis C Cure

When I last wrote about Gilead Sciences , on July 26, 2011, I said "A convergence of factors is driving Gilead profits higher.

Comment?

Thu Apr 26, 2012

Canadian Business Magazine

Gilead Sciences 1Q profit down on Pharmasset costs

HIV drug maker Gilead Sciences Inc.'s profit dropped 32 percent in the first quarter on costs related to its purchase of hepatitis C drug developer Pharmasset Inc.

Comment?

CBS News

Gilead Sciences 1Q profit down on Pharmasset costs

FOSTER CITY, Calif. &#8212 HIV drug maker Gilead Sciences Inc.'s profit dropped 32 percent in the first quarter on costs related to its purchase of hepatitis C drug developer Pharmasset Inc.

Comment?